Brief: Kiromic Biopharma Says Pietro Bersani Has Been Appointed Interim CEO
03/02/2022 14:57
Feb 3 (Reuters) - KIROMIC BIOPHARMA:
* KIROMIC BIOPHARMA INC SAYS PIETRO BERSANI HAS BEEN
APPOINTED
INTERIM CEO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site